Search research articles
Contact Us
Filters
Showing results (681-690 of 703) with videos related to
Page
of 71
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
December 28, 1999
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
R T Davey, N Bhat, C Yoder, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 28, 2005
Rapamycin analogs with reduced systemic exposure
Rolf Wagner, Karl W Mollison, Luping Liu, et al.
Cancer
|
May 31, 2014
Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck
Ron R Allison, Aaron A Ambrad, Youssef Arshoun, et al.
NEJM Evidence
|
December 8, 2024
Hydroxyurea for Children and Adults with Hemoglobin SC Disease
Yvonne A Dei-Adomakoh, Catherine I Segbefia, Teresa S Latham, et al.
Blood
|
July 11, 2000
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection
R E Walker, C M Bechtel, V Natarajan, et al.
Lancet (London, England)
|
September 11, 2007
Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys
Philip S Wang, Sergio Aguilar-Gaxiola, Jordi Alonso, et al.
Journal of Medicinal Chemistry
|
March 7, 2003
Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines
Philip R Kym, Michael E Kort, Michael J Coghlan, et al.
American Journal of Clinical Oncology
|
June 19, 2012
Postsurgical treatment of early-stage breast cancer with electronic brachytherapy: outcomes and health-related quality of life at 1 year
Rakesh R Patel, Peter D Beitsch, Timothy D Nichols, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 24, 2005
Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes
Peer B Jacobson, Thomas W von Geldern, Lars Ohman, et al.
Current Pharmaceutical Design
|
April 10, 1999
Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases
K W Mollison, T A Fey, D M Gauvin, et al.
Page
of 71
Search research articles
Search
Showing results (681-690 of 703) with videos related to
Sort By:
Page
of 71
Proceedings of the National Academy of Sciences of the United States of America
|
December 28, 1999
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
R T Davey, N Bhat, C Yoder, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 28, 2005
Rapamycin analogs with reduced systemic exposure
Rolf Wagner, Karl W Mollison, Luping Liu, et al.
Cancer
|
May 31, 2014
Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck
Ron R Allison, Aaron A Ambrad, Youssef Arshoun, et al.
NEJM Evidence
|
December 8, 2024
Hydroxyurea for Children and Adults with Hemoglobin SC Disease
Yvonne A Dei-Adomakoh, Catherine I Segbefia, Teresa S Latham, et al.
Blood
|
July 11, 2000
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection
R E Walker, C M Bechtel, V Natarajan, et al.
Lancet (London, England)
|
September 11, 2007
Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys
Philip S Wang, Sergio Aguilar-Gaxiola, Jordi Alonso, et al.
Journal of Medicinal Chemistry
|
March 7, 2003
Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines
Philip R Kym, Michael E Kort, Michael J Coghlan, et al.
American Journal of Clinical Oncology
|
June 19, 2012
Postsurgical treatment of early-stage breast cancer with electronic brachytherapy: outcomes and health-related quality of life at 1 year
Rakesh R Patel, Peter D Beitsch, Timothy D Nichols, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 24, 2005
Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes
Peer B Jacobson, Thomas W von Geldern, Lars Ohman, et al.
Current Pharmaceutical Design
|
April 10, 1999
Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases
K W Mollison, T A Fey, D M Gauvin, et al.
Page
of 71